Tobacco use, type 2 diabetes top risk factors for pancreatitis with obesity treatment

CHARLOTTE, N.C. — Tobacco use, type 2 diabetes and advanced chronic kidney disease increased the risk for acute pancreatitis after initiation of glucagon-like peptide-1 receptor agonists for weight loss, noted a presenter at the ACG Annual Scientific Meeting.However, a BMI of 36 kg/m2 or more had a protective effect against acute pancreatitis.“GLP-1RAs are effective and safe medications for the treatment of obesity. Despite the small risk of acute pancreatitis, they should still be used to treat obesity and comorbidities, like type 2 diabetes mellitus. However, as with allRead More